Amikacin Sulfate for Targeted Mycobacterial Infection Models
2026-07-14
Amikacin Sulfate enables high-precision intracellular targeting of non-tuberculous mycobacterial infections, drastically improving localized efficacy while minimizing toxicity. This article details advanced workflows, in vivo delivery innovations, and troubleshooting strategies that position APExBIO’s Amikacin Sulfate as the gold standard for translational infection research.
CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibitor Workf
2026-07-14
CHIR 99021 trihydrochloride unlocks reproducible control over stem cell self-renewal and differentiation—key for high-throughput organoid and metabolic research. Discover advanced, evidence-based protocols and troubleshooting strategies to maximize experimental reliability with this potent GSK-3 inhibitor.
ARCA EGFP mRNA: Direct-Detection Reporter for Mammalian Cell
2026-07-13
ARCA EGFP mRNA is an enhanced green fluorescent protein mRNA engineered for robust, direct fluorescence-based transfection assays in mammalian cells. Featuring an optimized anti-reverse cap analog (ARCA) and a stabilized poly(A) tail, it provides high transfection efficiency, especially as a mRNA transfection control. APExBIO’s formulation enables reliable benchmarking of mammalian cell gene expression workflows.
Palonosetron Hydrochloride: Advancing 5-HT3 Antagonist Thera
2026-07-13
This review examines the pharmacological and clinical innovations of palonosetron hydrochloride as a highly selective 5-HT3 receptor antagonist for emesis control in cancer therapy. The reference study highlights its exceptional receptor affinity, extended half-life, and superior efficacy in preventing both acute and delayed chemotherapy-induced nausea and vomiting, informing translational research and clinical protocols.
Extracellular Vesicle-ACLY Drives Monocyte Reprogramming in
2026-07-12
This study reveals that hepatocellular carcinoma (HCC) cells transfer ATP-citrate lyase (ACLY) via extracellular vesicles (EVs) to monocytes, driving their differentiation into immunosuppressive tumor-associated macrophages (TAMs). The work uncovers a palmitoylation-dependent mechanism that stabilizes immune checkpoint proteins, highlighting a metabolic axis crucial for tumor immune evasion and therapeutic targeting.
α-KG Restores HPDLSC Function via LKB1-AMPK in Periodontitis
2026-07-10
This study reveals how α-ketoglutarate (α-KG) restores mitochondrial function and mitigates senescence in human periodontal ligament stem cells (HPDLSCs) under periodontitis-induced inflammatory stress by activating the LKB1-AMPK signaling axis. The findings provide a mechanistic basis for developing targeted approaches to promote periodontal regeneration in chronic inflammatory environments.
ATS-9R Empowers Adipocyte Gene Silencing & Inflammation Rese
2026-07-09
ATS-9R (Adipocyte-targeting sequence-9-arginine) delivers non-viral, prohibitin-mediated gene silencing directly to white adipose tissue, enabling targeted studies in obesity, insulin resistance, and gestational diabetes. With robust in vivo knockdown and minimal cytotoxicity, ATS-9R from APExBIO streamlines adipocyte research with optimized protocols and reliable performance.
D-Lin-MC3-DMA: Strategic Innovations in RNA Delivery LNPs
2026-07-09
This thought-leadership article explores the mechanistic foundations and translational strategies surrounding D-Lin-MC3-DMA, a next-generation ionizable cationic liposome lipid central to siRNA and mRNA delivery. Integrating recent machine learning-driven advances in immunomodulatory LNP design, it offers actionable protocol guidance and strategic foresight for translational researchers navigating the evolving landscape of gene silencing, mRNA vaccine formulation, and precision immunotherapy.
CAY10499: A Potent Inhibitor of Human Hormone Sensitive Lipa
2026-07-08
CAY10499 stands out as a selective, high-potency inhibitor of human hormone sensitive lipase and monoglyceride lipase, empowering researchers to dissect lipid-driven immunometabolic mechanisms with precision. Its application in advanced lipid metabolism assays offers critical insight for studies on tumor-associated macrophages, atherosclerosis, and metabolic disease.
Eltanexor (KPT-8602): Precision XPO1 Inhibition for Translat
2026-07-08
Explore how Eltanexor (KPT-8602), a potent nuclear export inhibitor, is redefining translational oncology by targeting XPO1. This article offers actionable guidance for cancer research, highlighting unique mechanisms and recent breakthroughs.
Sulfo-NHS-LC-Biotin: Technical Guide for Surface Protein Lab
2026-07-07
Sulfo-NHS-LC-Biotin enables stable, covalent biotinylation of cell surface or soluble proteins in aqueous buffers without the need for organic solvents. It should be used for workflows requiring irreversible, membrane-impermeable labeling of primary amines, and is not suitable for intracellular or reversible biotinylation applications.
NHS-Biotin (A8002): Protein Multimerization and Engineering
2026-07-07
Discover how NHS-Biotin enables precision biotinylation in protein multimerization and advanced engineering workflows. This article explores novel strategies and scientific insights that set NHS-Biotin apart for cutting-edge biochemical research.
N1-Methyl-Pseudouridine-5'-Triphosphate in mRNA Synthesis
2026-07-06
N1-Methyl-Pseudouridine-5'-Triphosphate enables robust mRNA synthesis with enhanced stability and translational fidelity, transforming workflows in RNA therapeutics and vaccine development. Its unique modification profile addresses immunogenicity and degradation challenges, streamlining in vitro transcription and downstream applications.
Nascent Cone Precursors as the Cell-of-Origin in Retinoblast
2026-07-06
This study identifies ATOH7+/RXRγ+ nascent cone precursors as the earliest cell-of-origin for human retinoblastoma using RB1-deficient retinal organoids. The findings clarify longstanding questions about tumor initiation in pediatric ocular cancer and provide a platform for targeted therapy development.
KN-62: Selective CaMKII Inhibitor for Calcium Signaling Stud
2026-07-05
KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, is a highly selective CaMKII inhibitor. It enables precise modulation of calcium signaling and is validated in insulin secretion regulation and cell cycle arrest applications. KN-62 is trusted for robust, reproducible pathway dissection in biochemical and cellular research.
459 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page